Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

China to hold public trial of foreign couple who worked for GSK

Published 07/17/2014, 12:14 PM
Updated 07/17/2014, 12:20 PM
China to hold public trial of foreign couple who worked for GSK

By Michael Martina BEIJING (Reuters) - China will try in public a foreign couple linked to drugmaker GlaxoSmithKline Plc on charges of illegally obtaining private information, state media said, after the United States and Britain raised concerns about access to the trial.

Chinese prosecutors announced charges against British investigator Peter Humphrey and his U.S. wife on Monday. The couple were detained last year following work they did for the British pharmaceutical firm.

Two family friends with knowledge of the matter told Reuters this month that the trial was set for Aug. 7 and would be closed to the public. The secrecy around the trial had raised concerns among British and U.S. officials.

The couple "will be tried in public" the official Xinhua news agency said on Thursday, citing a statement from the Shanghai No.1 Intermediate People's Court.

"The two defendants hope their families can attend the trail," Xinhua said. It did not give further information on the decision.

The case against Humphrey and his wife, Yu Yingzeng, has become a key piece in a long-running investigation into GSK, whose China executives have been charged with orchestrating a widespread network of bribery to promote sales.

The U.S. and British embassies had pressed China on the need for a transparent and fair trial. The United States cited a 1982 bilateral consular convention between the two countries that it said gave officials permission to attend such trials.

China's Foreign Ministry had said the proceedings would be handled according to law.

ChinaWhys, the risk consultancy run by the couple, was employed by GSK in April 2013 to investigate a former employee suspected of sending anonymous emails, including the circulation of an intimate video of former GSK China head Mark Reilly with his girlfriend as well as emails containing allegations of widespread bribery at the British drugmaker.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Humphrey appeared on state-run China Central Television (CCTV) on Monday, saying he and his wife "deeply regret" breaking any Chinese law. He added that their firm would not have worked with GSK if the drugmaker had informed him about the full details of the whistleblower emails.

His apology reiterated a similar statement he made to CCTV in August last year after the couple were arrested.

Courts in China are tightly controlled by the ruling Communist Party, and defendants are almost always convicted. Access to trials is extremely limited.

"I am very pleased and grateful. I certainly want to attend the trial, and I can't wait to see my parents after more than a year," the couple's son, Harvey Humphrey, said in a statement sent to Reuters.

Xinhua had reported earlier that Humphrey and Yu had paid people in Beijing and Shanghai to purchase personal information. Citing the prosecutor on the case, the news agency alleged they had been fully aware of the illegality of their actions.

Between 2009 and 2013, the couple obtained private information through investigations into nearly 1,000 firms and a large number of private individuals, including household registration data, real estate and vehicle documents, and phone records, Xinhua added.

Humphrey had worked for Reuters as a journalist in the 1980s and 1990s.

(Additional reporting by John Ruwitch in Shanghai; editing by Jane Baird)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.